164 related articles for article (PubMed ID: 9885203)
1. A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications.
Harrison CN; Gale RE; Machin SJ; Linch DC
Blood; 1999 Jan; 93(2):417-24. PubMed ID: 9885203
[TBL] [Abstract][Full Text] [Related]
2. Clonal hemopoiesis and risk of thrombosis in young female patients with essential thrombocythemia.
Chiusolo P; La Barbera EO; Laurenti L; Piccirillo N; Sorà F; Giordano G; Urbano R; Mazzucconi MG; De Stefano V; Leone G; Sica S
Exp Hematol; 2001 Jun; 29(6):670-6. PubMed ID: 11378261
[TBL] [Abstract][Full Text] [Related]
3. Clonality analysis using X-chromosome inactivation patterns by HUMARA-PCR assay in female controls and patients with idiopathic thrombocytosis in Taiwan.
Shih LY; Lin TL; Dunn P; Wu JH; Tseng CP; Lai CL; Wang PN; Kuo MC
Exp Hematol; 2001 Feb; 29(2):202-8. PubMed ID: 11166459
[TBL] [Abstract][Full Text] [Related]
4. Clonality markers in polycythaemia and primary thrombocythaemia.
Briere J; el-Kassar N
Baillieres Clin Haematol; 1998 Dec; 11(4):787-801. PubMed ID: 10640217
[TBL] [Abstract][Full Text] [Related]
5. Predictive values of X-chromosome inactivation patterns and clinicohematologic parameters for vascular complications in female patients with essential thrombocythemia.
Shih LY; Lin TL; Lai CL; Dunn P; Wu JH; Wang PN; Kuo MC; Lee LC
Blood; 2002 Sep; 100(5):1596-601. PubMed ID: 12176877
[TBL] [Abstract][Full Text] [Related]
6. High telomerase activity in granulocytes from clonal polycythemia vera and essential thrombocythemia.
Ferraris AM; Mangerini R; Pujic N; Racchi O; Rapezzi D; Gallamini A; Casciaro S; Gaetani GF
Blood; 2005 Mar; 105(5):2138-40. PubMed ID: 15494424
[TBL] [Abstract][Full Text] [Related]
7. Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets.
el-Kassar N; Hetet G; Brière J; Grandchamp B
Blood; 1997 Jan; 89(1):128-34. PubMed ID: 8978285
[TBL] [Abstract][Full Text] [Related]
8. Clonality assays and megakaryocyte culture techniques in essential thrombocythemia.
Yan L; Elkassar N; Gardin C; Briere J
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():31-40. PubMed ID: 8951770
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic markers in essential thrombocythemia.
Gale RE
Curr Hematol Rep; 2003 May; 2(3):242-7. PubMed ID: 12901346
[TBL] [Abstract][Full Text] [Related]
10. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin.
Liu E; Jelinek J; Pastore YD; Guan Y; Prchal JF; Prchal JT
Blood; 2003 Apr; 101(8):3294-301. PubMed ID: 12515724
[TBL] [Abstract][Full Text] [Related]
11. Clonality analysis of hematopoiesis and thrombopoietin levels in patients with essential thrombocythemia.
El-Kassar N; Hetet G; Brière J; Grandchamp B
Leuk Lymphoma; 1998 Jun; 30(1-2):181-8. PubMed ID: 9669688
[TBL] [Abstract][Full Text] [Related]
12. PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia.
Vannucchi AM; Grossi A; Pancrazzi A; Antonioli E; Guglielmelli P; Balestri F; Biscardi M; Bulgarelli S; Longo G; Graziano C; Gugliotta L; Bosi A
Br J Haematol; 2004 Oct; 127(2):214-9. PubMed ID: 15461629
[TBL] [Abstract][Full Text] [Related]
13. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
14. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
[TBL] [Abstract][Full Text] [Related]
16. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
Brière J
Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
[TBL] [Abstract][Full Text] [Related]
17. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement.
Tsukamoto N; Morita K; Maehara T; Okamoto K; Sakai H; Karasawa M; Naruse T; Omine M
Br J Haematol; 1994 Feb; 86(2):253-8. PubMed ID: 7911034
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the long arm of chromosome 5 in essential thrombocythemia.
Reis MD; Sher GD; Lakhani A; Dubé ID; Senn JS; Pinkerton PH
Cancer Genet Cytogenet; 1992 Jul; 61(1):93-5. PubMed ID: 1638486
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of clonality assessment in JAK2V617F-negative essential thrombocythemia.
Martínez-Avilés L; Álvarez-Larrán A; Besses C; Navarro G; Torres E; Longarón R; Angona A; Pedro C; Florensa L; Serrano S; Bellosillo B
Ann Hematol; 2012 Oct; 91(10):1555-62. PubMed ID: 22706669
[TBL] [Abstract][Full Text] [Related]
20. Long-term serial analysis of X-chromosome inactivation patterns and JAK2 V617F mutant levels in patients with essential thrombocythemia show that minor mutant-positive clones can remain stable for many years.
Gale RE; Allen AJ; Nash MJ; Linch DC
Blood; 2007 Feb; 109(3):1241-3. PubMed ID: 17023581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
